What's New in Psoriasis: Pathophysiology, New Therapies, and the Road to Remission

20

Aug

2026 Thu

1 p.m. - 2 p.m.
Registration here.

This hybrid session is open to doctors and healthcare professionals only. 1 CME point will be awarded.

Psoriasis is far more than a skin condition — it's a systemic inflammatory disease with real implications for cardiology, rheumatology, gastroenterology, and mental health, often long before a patient ever sees a dermatologist. This session presents some of the recent developments in the past few years, including the first new non-steroidal topical medicine in decades, oral therapies approaching biologic-level efficacy, and next-generation biologics offering complete skin clearance as a realistic goal.


Our Speaker
 

Dr. Koh Hong Yi
Dermatologist

Dr. Koh Hong Yi is a consultant dermatologist with more than 20 years of clinical experience. He subspecializes in skin cancer, dermatologic surgery, Mohs micrographic surgery, psoriasis and phototherapy. Prior to private practice, Dr. Koh was a consultant dermatologist at Singapore General Hospital (SGH), where he founded the Mohs micrographic surgery service for high-risk skin cancers, and was the clinical lead for Psoriasis.